Oligometastatic Breast Cancer: Considering Patients One by One
![](https://academy.astro.org/sites/default/files/styles/course_image_teaser/public/OnlineCourses.jpg?itok=VNNiGZcY)
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
- SBRT
- Breast Cancer
Format
- CME only
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance